Characterization of the inhibition of hepatitis C virus entry byIn vitro-generated and patient-derived oxidized low-density lipoprotein

Characterization of Hepatitis C Virus Particle Subpopulations Reveals Multiple Usage of the Scavenger Receptor BI for Entry Steps

(2012) Viet Loan Dao Thi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice

(2012) Krzysztof Lacek et al.   JOURNAL OF HEPATOLOGY

Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

(2012) Bruno Sainz et al.   NATURE MEDICINE

Oxidized Low Density Lipoproteins-Do We Know Enough About Them?

(2011) Xueting Jiang et al.   CARDIOVASCULAR DRUGS AND THERAPY

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry

(2011) Sandra Ciesek et al.   HEPATOLOGY

Role of low-density lipoprotein receptor in the hepatitis C virus life cycle

(2011) Anna Albecka et al.   HEPATOLOGY

Immunosuppression, liver injury and post-transplant HCV recurrence

(2011) S. Ciesek et al.   JOURNAL OF VIRAL HEPATITIS

Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles

(2011) S. Ciesek et al.   JOURNAL OF VIROLOGY

Hepatitis c virus and host cell lipids: An intimate connection

(2011) Gualtiero Alvisi et al.   RNA Biology

Oxidized low-density lipoprotein is associated with viral load and disease activity in patients with chronic hepatitis C

(2011) Manouchehr Nakhjavani et al.   Clinics and Research in Hepatology and Gastroenterology

Evolving epidemiology of hepatitis C virus

(2010) D. Lavanchy   CLINICAL MICROBIOLOGY AND INFECTION

Glucocorticosteroids Increase Cell Entry by Hepatitis C Virus

(2010) Sandra Ciesek et al.   GASTROENTEROLOGY

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

(2010) Andrew J. Syder et al.   JOURNAL OF HEPATOLOGY

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

(2010) D. Bankwitz et al.   JOURNAL OF VIROLOGY

Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology

(2009) Irena Levitan et al.   ANTIOXIDANTS & REDOX SIGNALING

Scavenger receptor, Class B, Type I provides an alternative means for β-VLDL uptake independent of the LDL receptor in tissue culture

(2009) Clemens Röhrl et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants

(2009) M. T. Catanese et al.   JOURNAL OF VIROLOGY

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

(2008) J. Grove et al.   JOURNAL OF VIROLOGY